APA (7th ed.) Citation

JS, K., JD, R., ME, C., A, G., B, O., AB, H., . . . JD, G. (2022). A Phase 1 study of GDC-0134, a dual leucine zipper kinase inhibitor, in ALS. Annals of clinical and translational neurology, 9(1), 50. https://doi.org/10.1002/acn3.51491

Chicago Style (17th ed.) Citation

JS, Katz, et al. "A Phase 1 Study of GDC-0134, a Dual Leucine Zipper Kinase Inhibitor, in ALS." Annals of Clinical and Translational Neurology 9, no. 1 (2022): 50. https://doi.org/10.1002/acn3.51491.

MLA (9th ed.) Citation

JS, Katz, et al. "A Phase 1 Study of GDC-0134, a Dual Leucine Zipper Kinase Inhibitor, in ALS." Annals of Clinical and Translational Neurology, vol. 9, no. 1, 2022, p. 50, https://doi.org/10.1002/acn3.51491.